Literature DB >> 8116990

The relation of alcoholic myopathy to cardiomyopathy.

J Fernandez-Sola1, R Estruch, J M Grau, J C Pare, E Rubin, A Urbano-Marquez.   

Abstract

OBJECTIVE: To evaluate the relation between skeletal muscle disease (myopathy) and degenerative changes in cardiac muscle (cardiomyopathy) in patients with chronic alcoholism.
DESIGN: A cross-sectional study.
SETTING: University medical center. PARTICIPANTS: Group A included 24 patients with chronic alcoholism who had dilated cardiomyopathy; group B, 24 patients with chronic alcoholism who had normal cardiac function; group C, 12 patients with dilated cardiomyopathy because of coronary heart disease; group D, 12 patients with idiopathic dilated cardiomyopathy; group E, 24 normal participants; and group F, 5 young men who died suddenly in traffic accidents. MEASUREMENTS: Clinical assessment of muscle strength, echocardiography, radionuclide cardiac angiography (groups A to E), muscle biopsy (groups A, B, E), endomyocardial biopsy of the left ventricle (group A), and examination of postmortem specimens of the left ventricle (group F).
RESULTS: Alcoholic patients with cardiomyopathy had less muscle strength than did alcoholic patients with normal cardiac function, patients with idiopathic dilated cardiomyopathy, and patients with coronary heart disease (all P < 0.01). Among alcoholic patients with cardiomyopathy, 20 of 24 (83%) had histologic findings of skeletal myopathy compared with 1 of 24 (4%) alcoholic patients with normal cardiac function (P < 0.001). Interstitial fibrosis occurred in all cardiac biopsy specimens, hypertrophy of the myocytes occurred in 95%, and myocytolysis occurred in 83%. Those patients with more severe cellular hypertrophy and interstitial fibrosis of the myocardium had a greater decrease in deltoid muscle strength and had worse histologic myopathy.
CONCLUSIONS: Diseases of skeletal and cardiac muscle in patients with chronic alcoholism are clinically and histologically related. The presence of muscle weakness in an alcoholic person suggests the likelihood of an accompanying cardiomyopathic abnormality.

Entities:  

Mesh:

Year:  1994        PMID: 8116990     DOI: 10.7326/0003-4819-120-7-199404010-00001

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  27 in total

1.  Late ventricular potentials and heavy drinking.

Authors:  G Pochmalicki; M Genest; H Jibril
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

2.  Origins of cardiac dysfunction in cirrhosis.

Authors:  W Jiménez; V Arroyo
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 3.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

4.  Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

Authors:  L A Colombato; L Spahr; J P Martinet; M P Dufresne; M Lafortune; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

5.  Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.

Authors:  Ravi Bokarvadia; Mayank Jain; Chandankumar Kedarisetty; Joy Varghese; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2019-05-21

6.  A pilot study of a new chicken model of alcohol-induced cardiomyopathy.

Authors:  N Morris; C S Kim; A A Doye; R J Hajjar; N Laste; J K Gwathmey
Journal:  Alcohol Clin Exp Res       Date:  1999-10       Impact factor: 3.455

7.  E. coli endotoxin enhances cardiomyopathy in rats with chronic alcohol consumption.

Authors:  T Kita; T Nagano; K Kasai; N Tanaka
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

8.  Alcohol Differentially Alters Extracellular Matrix and Adhesion Molecule Expression in Skeletal Muscle and Heart.

Authors:  Jennifer L Steiner; Anne M Pruznak; Maithili Navaratnarajah; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2015-06-24       Impact factor: 3.455

9.  Protective effect of calpain inhibitor N-acetyl-L-leucyl-L-leucyl-L-norleucinal on acute alcohol consumption related cardiomyopathy.

Authors:  Kazim Kartkaya; Güngör Kanbak; Ayşegül Oğlakçı; Dilek Burukoğlu; Mehmet Caner Ozer
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

10.  Acute reversible left ventricular dysfunction secondary to alcohol.

Authors:  Saad Mahmoud; Luc M Beauchesne; Darryl R Davis; Christopher Glover
Journal:  Can J Cardiol       Date:  2007-05-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.